Ayman D. Allian’s educational and professional journey demonstrates how curiosity, perseverance and a willingness to embrace new opportunities can lead to extraordinary success. From his time at Moraine Valley to his current role as a senior director of engineering at global pharmaceutical corporation Eli Lilly and Company, Allian’s story reflects the power of exploration, mentorship and lifelong learning.
When Allian started at Moraine Valley in 1996, he was not certain which career path he wanted to pursue. Rather than rushing into a decision, he explored a variety of subjects and discovered a strong interest in chemistry, mathematics and physics. Initially considering a career in medicine, he found that engineering better aligned with his interests and strengths. Through Moraine Valley’s broad selection of courses and supportive advising, he connected all his interests and pursued a future in chemical engineering.
After graduating from the college in 1998 with an Associate in Science degree, Allian transferred to the University of Illinois Urbana-Champaign and continued his studies in chemical engineering. Following his undergraduate education in 2022, he studied abroad in Singapore, an experience that broadened his perspective and deepened his appreciation for learning beyond the classroom. After earning his doctorate at the National University of Singapore in 2006, he later returned to the U.S. and conducted postdoctoral research at UC Berkeley before beginning his career in the pharmaceutical industry. His willingness to embrace opportunities in new places became a defining theme throughout his career.
Today, Allian leads teams at Eli Lilly and Company responsible for developing and scaling manufacturing processes for medicines. He has contributed to treatments for hepatitis C, arthritis, obesity and diabetes. While he is proud of these accomplishments, some of his most meaningful moments come from hearing his wife, a pharmacist, describe dispensing medicines he helped develop to patients who need them.
Allian’s dedication and passion for the chemical engineering industry also have led to some impressive accolades. Through his work with Rinvoq, a medicine that treats certain immune-mediated diseases like psoriatic arthritis or Crohn’s disease, Allian and 24 other researchers received the 2025 Heroes of Chemistry Awards, presented by the American Chemical Society.
Equally important to Allian are the mentors who encouraged him. He credits a Moraine Valley chemistry professor for giving him confidence as a young immigrant still developing his English skills and encouraging him to continue his education when he sometimes doubted his own abilities. That encouragement helped him believe he could succeed.
“Students should remain open to opportunities, even when those opportunities take them outside their comfort zones,” Allian said. Reflecting on his own journey, he credits Moraine Valley with helping him to discover his future and providing a foundation for success.











